Obviohealth brings to light how decentralized clinical trials are becoming necessary to the entire clinical research industry. Read on to find out more
Orlando, United States - July 29, 2021 /PressCable/ —
ObvioHealth talks about how decentralized clinical trials are a necessary evolution within the clinical research industry. In the past, clinical trials were often viewed as burdensome by patients. Because of the inconveniences, recruitment rates are lower and retention rates are low, resulting in bloated budgets and little return on investment for sponsors.
Fortunately companies like ObvioHealth are transforming the traditional approach to research, through decentralized clinical trials. Through making participation easier and safer, the data collected for sponsors is much more effective and efficient, while saving on the budgets.
The benefits of decentralized clinical trials have been well documented in the past few years, with 2018 marking the year that then-FDA commissioner, Scott Gottlieb, highlighted the biggest of the benefits to decentralized clinical trials in a statement that describes this approach to “bring clinical trials to the patient, rather than always requiring the patient to travel to the investigator.”
Digital technologies narrow this gap and facilitate data collection that is more representative of the ‘real world’ by making research more accessible to participants. In a decentralized trial, data collection is usually conducted outside of the site visit for the most part, which makes it distinct from a site-based trial.
However, one of the bigger cons is that participants in DCTs may experience difficulties if they can’t easily communicate with the clinical staff. When carefully designed and executed, both of these issues are avoidable, and decentralized clinical trials can make life easier for all involved.
Until a year or two ago, researchers believed that these cons outweighed the pros, however this was more due to a reluctance to try new methods and risk aversion. This all changed during the COVID-19 pandemic.
To find out more about decentralized clinical trials or other services offered by ObvioHealth then visit their website at the following link: https://www.obviohealth.com/
Name: Tyler Davis
Email: Send Email
Organization: ObvioHealth USA, Inc.
Address: 3452 Lake Lynda Drive Suite 151, Orlando, Florida 32817, United States
Release ID: 89037008